The TLR4 agonist glucopyranosyl lipid adjuvant–stable emulsion (GLA-SE) can enhance T cell responses when combined with influenza split-virus vaccines (SVVs), significantly improving vaccine-mediated protection against influenza in older adults [112]. Here, TLR4 is linked to influenza.